maintenance of human cord blood shall remain avail-
able to the Secretary until the end of fiscal year 
2006 for the purpose of carrying out this section. 
(2) SUBSEQUENT
FISCAL
YEARS.—There are 
authorized to be appropriated to the Secretary 
$15,000,000 for each of fiscal years 2007, 2008, 
2009, and 2010 to carry out this section. Amounts 
appropriated pursuant to this paragraph shall re-
main available for obligation through the end of fis-
cal year 2010. 
SEC. 3. C.W. BILL YOUNG CELL TRANSPLANTATION PRO-
GRAM. 
(a) NATIONAL PROGRAM.—Section 379 of the Public 
Health Service Act (42 U.S.C. 274k) is amended—
(1) in the section heading, by striking ‘‘NA-
TIONAL
REGISTRY’’ and inserting ‘‘NATIONAL 
PROGRAM’’; 
(2) in subsection (a)—
(A) in the matter preceding paragraph (1), 
by striking ‘‘The Secretary shall by contract’’ 
and all that follows through the end of such 
matter and inserting ‘‘The Secretary, acting 
through the Administrator of the Health Re-
sources and Services Administration, shall by 
one or more contracts establish and maintain a
C.W. Bill Young Cell Transplantation Program 
that has the purpose of increasing the number 
of transplants for recipients suitably matched to 
biologically unrelated donors of bone marrow 
and cord blood, and that meets the require-
ments of this section. The Secretary may award 
a separate contract to perform each of the 
major functions of the Program described in 
paragraphs (1) and (2) of subsection (b) if 
deemed necessary by the Secretary to operate 
an effective and efficient system. The Secretary 
shall conduct a separate competition for the ini-
tial establishment of the cord blood functions of 
the Program. The Program shall be under the 
general supervision of the Secretary. The Sec-
retary shall establish an Advisory Council to ad-
vise, assist, consult with, and make rec-
ommendations to the Secretary on matters re-
lated to the activities carried out by the Pro-
gram. The members of the Advisory Council 
shall be appointed in accordance with the fol-
lowing:’’; 
(B) in paragraph (1), by striking ‘‘except 
that’’ and all that follows and inserting ‘‘except 
that—
‘‘(A) such limitations shall not apply to the 
Chair of the Advisory Council (or the Chair-
elect) or to the member of the Advisory Council 
who most recently served as the Chair; and 
‘‘(B) 1 additional consecutive 2-year term 
may be served by any member of the Advisory 
Council who has no employment, governance, or 
financial affiliation with any donor center, re-
cruitment group, transplant center, or cord 
blood stem cell bank.’’; 
(C) by amending paragraph (4) to read as 
follows: 
‘‘(4) The membership of the Advisory Council—
‘‘(A) shall include as voting members a 
balanced number of representatives including 
representatives of marrow donor centers and 
marrow transplant centers, representatives of 
cord blood stem cell banks and participating 
birthing hospitals, recipients of a bone marrow 
transplant and cord blood transplants, persons 
who require such transplants, family members 
of such a recipient or family members of a pa-
tient who has requested the assistance of the 
Program in searching for an unrelated donor of 
bone marrow or cord blood, persons with exper-
tise in blood stem cell transplantation including 
cord blood, persons with expertise in typing, 
matching, and transplant outcome data anal-
ysis, persons with expertise in the social 
sciences, and members of the general public; 
and 
‘‘(B) shall include as nonvoting members 
representatives from the Department of De-
fense Marrow Donor Recruitment and Research 
Program operated by the Department of the 
Navy, the Division of Transplantation of the 
Health Resources and Services Administration, 
the Food and Drug Administration, and the 
National Institutes of Health.’’; and 
(D) by adding at the end the following: 
‘‘(5) Members of the Advisory Council shall be 
chosen so as to ensure objectivity and balance and 
reduce the potential for conflicts of interest. The 
Secretary shall establish bylaws and procedures—
‘‘(A) to prohibit any member of the Advi-
sory Council who has an employment, govern-
ance, or financial affiliation with a donor cen-
ter, recruitment group, transplant center, or 
cord blood stem cell bank from participating in 
any decision that materially affects the center,
recruitment group, transplant center, or cord 
blood stem cell bank; and 
‘‘(B) to limit the number of members of 
the Advisory Council with any such affiliation. 
‘‘(6) The Secretary, acting through the Advi-
sory Council, shall submit to the Congress—
‘‘(A) an annual report on the activities car-
ried out under this section; and 
‘‘(B) not later than 6 months after the 
date of the enactment of the Stem Cell Thera-
peutic and Research Act of 2005, a report of 
recommendations on the scientific factors nec-
essary to define a cord blood unit as a high-
quality unit.’’; 
(3) by amending subsection (b) to read as fol-
lows: 
‘‘(b) FUNCTIONS.—
‘‘(1) BONE MARROW FUNCTIONS.—With respect 
to bone marrow, the Program shall—
‘‘(A) operate a system for listing, search-
ing, and facilitating the distribution of bone 
marrow that is suitably matched to candidate 
patients; 
‘‘(B) carry out a program for the recruit-
ment of bone marrow donors in accordance with
subsection (c), including with respect to increas-
ing the representation of racial and ethnic mi-
nority groups (including persons of mixed an-
cestry) in the enrollment of the Program; 
‘‘(C) maintain and expand medical emer-
gency contingency response capabilities in con-
cert with Federal programs for response to 
threats of use of terrorist or military weapons 
that can damage marrow, such as ionizing radi-
ation or chemical agents containing mustard, so 
that the capability of supporting patients with 
marrow damage from disease can be used to 
support casualties with marrow damage; 
‘‘(D) carry out informational and edu-
cational activities in accordance with subsection 
(c); 
‘‘(E) at least annually update information 
to account for changes in the status of individ-
uals as potential donors of bone marrow; 
‘‘(F) provide for a system of patient advo-
cacy through the office established under sub-
section (d); 
‘‘(G) provide case management services for 
any potential donor of bone marrow to whom 
the Program has provided a notice that the po-